Does Oncomed Pharma Have Any Upside Left?

By: via Benzinga
Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares are down 52 percent since July 27. Leerink’s Paul Matteis ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.